Advertisement
Research Article| Volume 12, ISSUE 3, P587-602, September 1992

Hemapheresis in Pregnancy*

  • R. Ben Dawson
    Correspondence
    Address reprint requests to: R. Ben Dawson, MD, Baltimore Rh Typing Laboratory, 400 W. Franklin Street, Baltimore, MD 21201
    Affiliations
    From the University of Maryland School of Medicine; and the Therapeutic Apheresis Center, Baltimore Rh Typing Laboratory, Baltimore, Maryland
    Search for articles by this author
  • Author Footnotes
    * This article is dedicated to the memory of Isadore Siegel, MD, a founder of the Baltimore Rh Typing Laboratory in 1945, and to the prescient wisdom of Lois A. Bilenki, technologist and manager who for four decades inspired innovation and facilitated development and progress in the diagnosis and treatment of human disease in hematology, pregnancy, and transfusion medicine.
DOI:https://doi.org/10.1016/S0272-2712(18)30507-9
Hemapheresis in Pregnancy*
Previous ArticleNeonatal Alloimmune Thrombocytopenia
Next ArticleAssessment of Fetal Lung Maturity by Laboratory Methods
      This paper is only available as a PDF. To read, Please Download here.
      Hemapheresis, the removal of part of an individual’s blood with the remainder returned to the individual, is generally as safe in pregnant as in nonpregnant individuals. Three additional conditions, however, are of particular significance to the pregant patient: hemolytic disease of the newborn, increased maternal-fetal mortality in the patient with sickle cell disease; and thrombotic thrombocyopenic purpura and hemolytic uremic syndrome disorders. Topics include technology, plasma and blood volume calculations and considerations, and therapeutic hemapheresis.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Abel J.J.
        • Rowntree L.G.
        • Turner B.B.
        Plasma removal with return of corpuscles (plasmapheresis.
        J Pharmacol Exp Ther. 1914; 5: 625-641
        • Bell W.R.
        • Braine H.G.
        • Ness P.M.
        • et al.
        Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.
        Clinical experience in 108 patients. N Engl J Med. 1991; 325: 398-403
        • Bruckner C.D.
        • Clift R.
        • Thomas E.D.
        Plasma exchange with NCI-IBM blood cell separator.
        Rev Fr Clin Biol. 1969; 14: 803
        • Buffaloe G.W.
        • Heineken F.G.
        Plasma volume nomograms for use in therapeutic plasma exchange.
        Transfusion. 1983; 23: 355-357
        • Caggiano V.
        • Fernando L.P.
        • Schneider J.M.
        • et al.
        Thrombotic thrombocytopenic purpura.
        Report of 14 cases: Occurrence during pregnancy and response to plasma exchange. J Clin Apheresis. 1983; 1: 71-85
        • The Canadian Cooperative Multiple Sclerosis Study Group
        The Canadian Cooperative Trial of cyclophosphamide and plasma exchange in progressive multiple sclerosis.
        Lancet. 1991; 337: 441-446
        • Chopek M.
        • McCullough J.
        Protein and biochemical changes during plasma exchange.
        in: Berkman E.M. Umlas J. Therapeutic Hemapheresis. American Association of Blood Banks, Washington, DC1980: 13-52
        • Clinical applications of therapeutic apheresis
        Report of the Clinical Applications Committee, American Society for Apheresis.
        J Clin Apheresis. 1986; 3: 21-22
        • Crispen J.F.
        Medical ethics and the morality of plasmapheresis.
        Plasma Forum. 1978; 1: 39
        • Dawson R.B.
        Therapeutic apheresis.
        MD Med J. 1987; 36: 1037-1039
        • Dawson R.B.
        • Bilenki L.A.
        • Wenk R.E.
        Increased albumin levels within two weeks of starting twice-weekly plasma exchange.
        J Clin Apheresis. 1984; 2: 139
        • Dawson R.B.
        • Seiguer A.S.
        • Edelman B.B.
        • et al.
        Substitution therapy in plasma exchange.
        in: Nose Y. Malchesky E.S. Smith J.W. Plasmapheresis. Raven Press, New York1983: 65-73
        • Dawson R.B.
        • Wenk R.E.
        • Desaunier S.
        Gamma globulin prophylaxis in intensive long-term plasma exchange.
        Ann Clin Lab Sei. 1987; 17: 268-269
        • Dyck P.J.
        • Daube J.
        • O’Brien P.
        • et al.
        Plasma exchange in chronic inflammatory demyelinating polyneuropathy.
        N Engl J Med. 1986; 314: 461-465
        • Guillaine-Barre’ Syndrome Study Group
        Plasmapheresis and acute Guillaine-Barre’ syndrome.
        Neurology. 1985; 35: 1096-1104
        • Guillerin L.
        • Bussei A.
        • Schooneman F.
        • et al.
        Viscosity as the symptom leading to plasma exchange.
        Curr Stud Hematol Blood Transfus. 1990; 57: 220-238
        • Hafler D.A.
        • Johnson P.
        • Kelly H.
        • et al.
        Monoclonal gammopathy and neuropathy: Myelin-associated glycoprotein reactivity and clinical characteristics.
        Neurology. 1986; 36: 75-78
        • Hustin A.
        Principe d’une nouvelle methode de transfusion muquesuse.
        J Med Brux. 1914; 2: 436
        • Khatri B.O.
        • McQuillen M.P.
        • Harrington G.J.
        Chronic progressive multiple sclerosis: Doubleblind controlled study of plasmapheresis in patients taking immunosuppressive drugs.
        Neurology. 1985; 35: 312-319
        • Khatri B.O.
        • McQuillen M.P.
        • Hoffman R.G.
        • et al.
        Plasma exchange in chronic progressive multiple sclerosis: A long-term study.
        Neurology. 1991; 41: 409-413
        • Klein H.G.
        Effect of plasma exchange on plasma constituents: Choice of replacement solutions and kinetics of exchange.
        in: MacPherson J.L. Kasprisin D.O. Therapeutic Hemapheresis. Vol 2. FL, CRC Press, Boca Raton1985: 84-94
        • Lian E.C.-Y.
        • Byrnes J.J.
        • Harkness D.R.
        Two successful pregnancies in a woman with clinic thrombotic thrombocytopenic purpura treated by plasma infusion.
        Am J Hematol. 1984; 16: 287-291
        • Lundsgaard-Hansen P.
        Physiology and pathophysiology of colloid osmotic pressure and albumin metabolism.
        Curr Stud Hematol Blood Transfus. 1986; 53: 1-17
        • NIH Consensus Conference
        The utility of therapeutic plasmapheresis for neurologic disorders.
        JAMA. 1986; 256: 1333-1337
        • Powell L.C.
        Intensive plasmapheresis in the pregnant Rh-sensitized woman.
        Am J Obstet Gynecol. 1968; 101: 153-170
        • Robinson A.E.
        • Tovey L.A.D.
        Intensive plasma exchange in the management of severe Rh disease.
        Br J Haematol. 1980; 45: 621
        • Rock G.
        Plasma exchange for antibody removal in hemolytic disease of the newborn.
        in: MacPherson J.L. Kasprisin D.O. Therapeutic Hemapheresis. Vol 2. FL, CRC Press, Boca Raton1985: 100-116
        • Rock G.A.
        • Shumak K.H.
        • Buskard N.A.
        • et al.
        Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura.
        N Engl J Med. 1991; 325: 393-397
        • Schanfield M.S.
        Antibody-mediated perinatal diseases.
        Clin Lab Med. 1981; 1: 239-264
        • Solomon A.
        • Fahey J.L.
        Plasmapheresis therapy and macroglobulinemia.
        Ann Intern Med. 1963; 58: 789-800
        • Sprenger K.B.G.
        • Huber K.
        • Kratz W.
        • et al.
        Nomograms for the prediction of patient’s plasma volume in plasma exchange therapy from height, weight, and hematocrit.
        J Clin Apheresis. 1987; 3: 185-190
        • Upshaw J.D.
        • Reidy T.J.
        • Groshart K.
        Thrombotic thrombocytopenic purpura in pregnancy: Response to plasma manipulations.
        South Med J. 1985; 78: 677-680
        • Weiner C.P.
        Thrombotic microangiopathy in pregnancy and the postpartum period.
        Semin Hematol. 1987; 24: 119-129
        • Weiner H.L.
        • Dau P.C.
        • Khatri B.O.
        • et al.
        Double-blind study of true vs sham plasma exchange in patients treated with immunosuppressant multiple sclerosis.
        Neurology. 1989; 39: 1143-1149

      Article info

      Identification

      DOI: https://doi.org/10.1016/S0272-2712(18)30507-9

      Copyright

      © 1992 Elsevier Inc. Published by Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX